Millions of people around the world suffer and die from diseases that are treatable and nonfatal. These people are mainly the poor, especially those in Sub-Saharan Africa. They have little if any access to pharmaceuticals; indeed, the diseases that particularly affect them are hardly researched. Appropriate drugs have not been developed; the health care infrastructure is seriously deficient.